Alterity Therapeutics ATHE
NASDAQ ATHE
$2.31 +0.01 (+0.43%)
As of: Nov 11, 2026 · 3:59 PM EST

Alterity Therapeutics (ATHE) EBIT (2016 - 2018)

Updated

Alterity Therapeutics (ATHE) recorded EBIT of -$16.52 trillion in the year ended Jun 30, 2026, compared with -$7.74 trillion a year earlier.

Analysis

Alterity Therapeutics (ATHE) EBIT (2016 - 2018) Analysis & Trends

Starting with the year ended Jun 30, 2009, Alterity Therapeutics' EBIT history includes 18 years.

  • The figure for the year ended Jun 30, 2026 is the lowest annual EBIT in data going back to the year ended Jun 30, 2009.
  • Per Business Quant data, ATHE's EBIT was -$7.74 trillion in the year ended Jun 30, 2025, -$190,774 in the year ended Aug 29, 2024, -$137,021 in the year ended Dec 31, 2023 and -$9.15 trillion in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.27 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.39 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.46 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.47 Bn
10 Alterity Therapeutics 42.05 Mn -41.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -3.83 Mn
Dec 31, 2017 -2.78 Mn
Dec 31, 2016 -2.74 Mn
API Access

Alterity Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ATHE&period=max&api_key=YOUR_API_KEY